---
figid: PMC4621978__BPH-172-4847-g009
figlink: /pmc/articles/PMC4621978/figure/bph13254-fig-0009/
number: F9
caption: Schematic representation of δ receptor‐mediated ERK1/2 activation via the
  PKCδ/EGFR/β‐arrestin2 signalling pathway in response to specific agonist stimulation.
  DPDPE binding to δ receptors results in the dissociation of heterotrimeric G‐proteins
  into Gα‐GTP and Gβγ subunits. Gβγ subunit release leads to the recruitment and activation
  of Src, which causes tyrosine phosphorylation of the δ receptors, producing an SH2
  site that might bind to Shc, Grb2 and additional downstream molecules to activate
  the Ras‐dependent ERK cascade, whereas the binding of TIPP or morphine to δ receptors
  activates PKCδ rather than Src, which results in the activation of metalloproteinase
  (MMP), release of heparin‐binding EGF‐like factor (HB‐EGF) and transactivation of
  EGFR. The transactivated EGFR can then activate ERK1/2 by recruiting β‐arrestins
  as a scaffold to assemble component kinases of the ERK cascade. Mutation of the
  Ser363 residue of the δ receptor can switch DPDPE from activation of Src to activation
  of PKCδ and thus allows it gain the ability to appropriate the PKCδ/EGFR/β‐arrestin2
  signalling pathway to activate ERK1/2.
pmcid: PMC4621978
papertitle: Role for engagement of β‐arrestin2 by the transactivated EGFR in agonist‐specific
  regulation of δ receptor activation of ERK1/2.
reftext: Le‐Sha Zhang, et al. Br J Pharmacol. 2015 Oct;172(20):4847-4863.
pmc_ranked_result_index: '16903'
pathway_score: 0.9687364
filename: BPH-172-4847-g009.jpg
figtitle: D receptor‐mediated ERK1/2 activation via the PKCD/EGFR/B‐arrestin2 signalling
  pathway in response to specific agonist stimulation
year: '2015'
organisms:
- Homo sapiens
ndex: 4bf71c91-dec9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4621978__BPH-172-4847-g009.html
  '@type': Dataset
  description: Schematic representation of δ receptor‐mediated ERK1/2 activation via
    the PKCδ/EGFR/β‐arrestin2 signalling pathway in response to specific agonist stimulation.
    DPDPE binding to δ receptors results in the dissociation of heterotrimeric G‐proteins
    into Gα‐GTP and Gβγ subunits. Gβγ subunit release leads to the recruitment and
    activation of Src, which causes tyrosine phosphorylation of the δ receptors, producing
    an SH2 site that might bind to Shc, Grb2 and additional downstream molecules to
    activate the Ras‐dependent ERK cascade, whereas the binding of TIPP or morphine
    to δ receptors activates PKCδ rather than Src, which results in the activation
    of metalloproteinase (MMP), release of heparin‐binding EGF‐like factor (HB‐EGF)
    and transactivation of EGFR. The transactivated EGFR can then activate ERK1/2
    by recruiting β‐arrestins as a scaffold to assemble component kinases of the ERK
    cascade. Mutation of the Ser363 residue of the δ receptor can switch DPDPE from
    activation of Src to activation of PKCδ and thus allows it gain the ability to
    appropriate the PKCδ/EGFR/β‐arrestin2 signalling pathway to activate ERK1/2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MMP2
  - MMP8
  - MMP19
  - MMP12
  - MMP9
  - MMP10
  - MMP11
  - MMP1
  - GRK6
  - ARAF
  - RAF1
  - MMP27
  - MMP25
  - EGFR
  - MAPK3
  - MAPK1
  - HBEGF
  - MAP2K2
  - GRK3
  - GRK4
  - GRK5
  - MMP28
  - MMP24
  - MMP21
  - MMP3
  - MMP7
  - SRC
  - MMP23B
  - MMP20
  - EIF2AK3
  - GRK1
  - GRK2
  - GRK7
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - BRAF
  - MAP2K1
  - Morphine
  - Ser
  - DPDPE
  - Cancer
genes:
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP8
  entrez: '4317'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP19
  entrez: '4327'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP12
  entrez: '4321'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP11
  entrez: '4320'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK6
  entrez: '2870'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP27
  entrez: '64066'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP25
  entrez: '64386'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: HB-EGF
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK3
  entrez: '157'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK4
  entrez: '2868'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK5
  entrez: '2869'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP28
  entrez: '79148'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP24
  entrez: '10893'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP21
  entrez: '118856'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP23B
  entrez: '8510'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP20
  entrez: '9313'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK1
  entrez: '6011'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK2
  entrez: '156'
- word: P-GRK
  symbol: GRK
  source: bioentities_symbol
  hgnc_symbol: GRK7
  entrez: '131890'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP14
  entrez: '4323'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP15
  entrez: '4324'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP17
  entrez: '4326'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Mek
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals:
- word: Morphine
  source: MESH
  identifier: D009020
- word: Ser
  source: MESH
  identifier: D012694
- word: DPDPE
  source: MESH
  identifier: D020881
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC4621978__F9
redirect_from: /figures/PMC4621978__F9
figtype: Figure
---
